Selected research
Industry Research
Poloxamer 338 Industry Research Report 2026
Market perspective
The global Poloxamer 338 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Poloxamer 338 is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Poloxamer 338 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Poloxamer 338 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Poloxamer 338 include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Poloxamer 338 market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Poloxamer 338.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Poloxamer 338 Market by Company
BASF
Croda
Comercial Química Massó
CD Formulation
Poloxamer 338 Segment by Type
Purity 99%
Purity 99.9%
Others
Poloxamer 338 Segment by Application
Cosmetic
Pharmaceuticals
Others
Poloxamer 338 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer 338 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Poloxamer 338 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer 338.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Poloxamer 338 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Poloxamer 338 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Poloxamer 338 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 99%
- Purity 99.9%
- Others
Applications
- Cosmetic
- Pharmaceuticals
- Others
Companies covered
- BASF
- Croda
- Comercial Química Massó
- CD Formulation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Poloxamer 338 by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Purity 99%
- 2.2.3 Purity 99.9%
- 2.2.4 Others
- 2.3 Poloxamer 338 by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cosmetic
- 2.3.3 Pharmaceuticals
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Poloxamer 338 Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Poloxamer 338 Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Poloxamer 338 Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Poloxamer 338 Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Poloxamer 338 Production by Manufacturers (2021-2026)
- 3.2 Global Poloxamer 338 Production Value by Manufacturers (2021-2026)
- 3.3 Global Poloxamer 338 Average Price by Manufacturers (2021-2026)
- 3.4 Global Poloxamer 338 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Poloxamer 338 Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Poloxamer 338 Manufacturers, Product Type & Application
- 3.7 Global Poloxamer 338 Manufacturers Established Date
- 3.8 Global Poloxamer 338 Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BASF
- 4.1.1 BASF Poloxamer 338 Company Information
- 4.1.2 BASF Poloxamer 338 Business Overview
- 4.1.3 BASF Poloxamer 338 Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 BASF Product Portfolio
- 4.1.5 BASF Recent Developments
- 4.2 Croda
- 4.2.1 Croda Poloxamer 338 Company Information
- 4.2.2 Croda Poloxamer 338 Business Overview
- 4.2.3 Croda Poloxamer 338 Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Croda Product Portfolio
- 4.2.5 Croda Recent Developments
- 4.3 Comercial Química Massó
- 4.3.1 Comercial Química Massó Poloxamer 338 Company Information
- 4.3.2 Comercial Química Massó Poloxamer 338 Business Overview
- 4.3.3 Comercial Química Massó Poloxamer 338 Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Comercial Química Massó Product Portfolio
- 4.3.5 Comercial Química Massó Recent Developments
- 4.4 CD Formulation
- 4.4.1 CD Formulation Poloxamer 338 Company Information
- 4.4.2 CD Formulation Poloxamer 338 Business Overview
- 4.4.3 CD Formulation Poloxamer 338 Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 CD Formulation Product Portfolio
- 4.4.5 CD Formulation Recent Developments
5 Global Poloxamer 338 Production by Region
- 5.1 Global Poloxamer 338 Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Poloxamer 338 Production by Region: 2021-2032
- 5.2.1 Global Poloxamer 338 Production by Region: 2021-2026
- 5.2.2 Global Poloxamer 338 Production Forecast by Region (2027-2032)
- 5.3 Global Poloxamer 338 Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Poloxamer 338 Production Value by Region: 2021-2032
- 5.4.1 Global Poloxamer 338 Production Value by Region: 2021-2026
- 5.4.2 Global Poloxamer 338 Production Value Forecast by Region (2027-2032)
- 5.5 Global Poloxamer 338 Market Price Analysis by Region (2021-2026)
- 5.6 Global Poloxamer 338 Production and Value, YOY Growth
- 5.6.1 North America Poloxamer 338 Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Poloxamer 338 Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Poloxamer 338 Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Poloxamer 338 Production Value Estimates and Forecasts (2021-2032)
6 Global Poloxamer 338 Consumption by Region
- 6.1 Global Poloxamer 338 Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Poloxamer 338 Consumption by Region (2021-2032)
- 6.2.1 Global Poloxamer 338 Consumption by Region: 2021-2026
- 6.2.2 Global Poloxamer 338 Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Poloxamer 338 Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Poloxamer 338 Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Poloxamer 338 Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Poloxamer 338 Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Poloxamer 338 Production by Type (2021-2032)
- 7.1.1 Global Poloxamer 338 Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Poloxamer 338 Production Market Share by Type (2021-2032)
- 7.2 Global Poloxamer 338 Production Value by Type (2021-2032)
- 7.2.1 Global Poloxamer 338 Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Poloxamer 338 Production Value Market Share by Type (2021-2032)
- 7.3 Global Poloxamer 338 Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Poloxamer 338 Production by Application (2021-2032)
- 8.1.1 Global Poloxamer 338 Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Poloxamer 338 Production Market Share by Application (2021-2032)
- 8.2 Global Poloxamer 338 Production Value by Application (2021-2032)
- 8.2.1 Global Poloxamer 338 Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Poloxamer 338 Production Value Market Share by Application (2021-2032)
- 8.3 Global Poloxamer 338 Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Poloxamer 338 Value Chain Analysis
- 9.1.1 Poloxamer 338 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Poloxamer 338 Production Mode & Process
- 9.2 Poloxamer 338 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Poloxamer 338 Distributors
- 9.2.3 Poloxamer 338 Customers
10 Global Poloxamer 338 Analyzing Market Dynamics
- 10.1 Poloxamer 338 Industry Trends
- 10.2 Poloxamer 338 Industry Drivers
- 10.3 Poloxamer 338 Industry Opportunities and Challenges
- 10.4 Poloxamer 338 Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst